ロード中...
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
Bruton’s tyrosine kinase (BTK) signaling is involved in innate immune responses and regulates the production of proinflammatory cytokines that can contribute to COVID-19 immunopathology. Clinical trials with BTK inhibitors in COVID-19 treatment have been proposed, and previous studies have attempted...
保存先:
| 出版年: | J Leukoc Biol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361550/ https://ncbi.nlm.nih.gov/pubmed/32640487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/JLB.5COVR0620-306R |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|